FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200425478> ?p ?o ?g. }

• W4200425478 endingPage "4029" @default.
• W4200425478 startingPage "4017" @default.
• W4200425478 abstract "Background: Camel urine (CU) has been used as traditional treatment in the Arabian Peninsula for centuries. Although, researchers have reported CU anti-cancer effects, the exact mechanism(s) of action involved has not been fully elucidated. The epithelial–mesenchymal transition EMT is a phenotypic switch that promotes the acquisition of a fibroblastoid-like morphology by epithelial tumor cells, resulting in enhanced tumor cell motility and invasiveness. EMT has been shown to contribute to metastasis and chemoresistance of carcinomas. For that, in the present study, we have assessed the potential mechanism (s) by which CU exert its anti-cancer effects and its possible synergistic therapeutic effect with Doxorubicin (DOX) in breast cancer cells. Methods: Determination of anti-proliferative and apoptosis validation of CU was performed by 3-(4,5-Dimethylthiazol-2-yl)-2,5,-diphenyltetrazolium bromide (MTT), annexin-V-fluorescein isothiocyanate assays, and Western blot. EMT protein markers, migration and invasion of cells were determined by Western blot or immunofluorescent staining, Scratch assay, Transwell invasion assay, respectively. Results: CU applied a significant anti-cancer effect on breast cancer cells via induction of DNA damage and apoptosis in a concentration- and time-dependent manner. Also, CU remarkably reversed the EMT by downregulating N-cadherin and Vimentin expression and upregulating E-cadherin expression. As a result, the stemness, migration and invasion of breast cancer cells were also inhibited, which was likely mediated by NF-κB-Snail signalling pathway and its downstream inflammatory effectors. CU successfully enhanced DOX cytotoxicity by reversing EMT which possibly through inhibition of NF-κB-Snail signalling and subsequently inflammation. Thus, our study provides new mechanistic bases for the therapeutic application of CU that may improve the outcomes of anti-cancer chemotherapy." @default.
• W4200425478 created "2021-12-31" @default.
• W4200425478 creator A5024882773 @default.
• W4200425478 creator A5040044756 @default.
• W4200425478 creator A5076057191 @default.
• W4200425478 creator A5081308272 @default.
• W4200425478 date "2021-12-01" @default.
• W4200425478 modified "2023-09-25" @default.
• W4200425478 title "Camel Urine Promotes Sensitization to Doxorubicin by Inhibiting Epithelial-Mesenchymal Transition and Modulating NF-κB-Snail Signaling Pathway in Breast Cancer Cells" @default.
• W4200425478 cites W1452071823 @default.
• W4200425478 cites W1571529930 @default.
• W4200425478 cites W1964081206 @default.
• W4200425478 cites W1964825240 @default.
• W4200425478 cites W1968122636 @default.
• W4200425478 cites W1973354681 @default.
• W4200425478 cites W1973610643 @default.
• W4200425478 cites W1977322720 @default.
• W4200425478 cites W1985122789 @default.
• W4200425478 cites W1985785895 @default.
• W4200425478 cites W1990461493 @default.
• W4200425478 cites W1992101294 @default.
• W4200425478 cites W1995302014 @default.
• W4200425478 cites W1995394695 @default.
• W4200425478 cites W1995778320 @default.
• W4200425478 cites W1997602840 @default.
• W4200425478 cites W1998166198 @default.
• W4200425478 cites W2009663080 @default.
• W4200425478 cites W2014691022 @default.
• W4200425478 cites W2015690196 @default.
• W4200425478 cites W2019774245 @default.
• W4200425478 cites W2028593825 @default.
• W4200425478 cites W2037268646 @default.
• W4200425478 cites W2038676766 @default.
• W4200425478 cites W2041365221 @default.
• W4200425478 cites W2042198997 @default.
• W4200425478 cites W2049807952 @default.
• W4200425478 cites W2053271495 @default.
• W4200425478 cites W2059158933 @default.
• W4200425478 cites W2079750277 @default.
• W4200425478 cites W2080232352 @default.
• W4200425478 cites W2080434084 @default.
• W4200425478 cites W2095069572 @default.
• W4200425478 cites W2096539796 @default.
• W4200425478 cites W2108369647 @default.
• W4200425478 cites W2110678035 @default.
• W4200425478 cites W2116628300 @default.
• W4200425478 cites W2118278569 @default.
• W4200425478 cites W2123700568 @default.
• W4200425478 cites W2124185479 @default.
• W4200425478 cites W2137267184 @default.
• W4200425478 cites W2142641037 @default.
• W4200425478 cites W2143841612 @default.
• W4200425478 cites W2146279127 @default.
• W4200425478 cites W2150322923 @default.
• W4200425478 cites W2153086428 @default.
• W4200425478 cites W2154589460 @default.
• W4200425478 cites W2164618834 @default.
• W4200425478 cites W2167540108 @default.
• W4200425478 cites W2171632978 @default.
• W4200425478 cites W2299031748 @default.
• W4200425478 cites W2315613727 @default.
• W4200425478 cites W2338081144 @default.
• W4200425478 cites W2464753040 @default.
• W4200425478 cites W2526519857 @default.
• W4200425478 cites W2557875611 @default.
• W4200425478 cites W2586820110 @default.
• W4200425478 cites W2792079734 @default.
• W4200425478 cites W2999417355 @default.
• W4200425478 cites W3128646645 @default.
• W4200425478 cites W329007366 @default.
• W4200425478 doi "https://doi.org/10.31557/apjcp.2021.22.12.4017" @default.
• W4200425478 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34967584" @default.
• W4200425478 hasPublicationYear "2021" @default.
• W4200425478 type Work @default.
• W4200425478 citedByCount "3" @default.
• W4200425478 countsByYear W42004254782022 @default.
• W4200425478 countsByYear W42004254782023 @default.
• W4200425478 crossrefType "journal-article" @default.
• W4200425478 hasAuthorship W4200425478A5024882773 @default.
• W4200425478 hasAuthorship W4200425478A5040044756 @default.
• W4200425478 hasAuthorship W4200425478A5076057191 @default.
• W4200425478 hasAuthorship W4200425478A5081308272 @default.
• W4200425478 hasBestOaLocation W42004254781 @default.
• W4200425478 hasConcept C104317684 @default.
• W4200425478 hasConcept C121608353 @default.
• W4200425478 hasConcept C126322002 @default.
• W4200425478 hasConcept C147447768 @default.
• W4200425478 hasConcept C185592680 @default.
• W4200425478 hasConcept C18903297 @default.
• W4200425478 hasConcept C190283241 @default.
• W4200425478 hasConcept C203014093 @default.
• W4200425478 hasConcept C204232928 @default.
• W4200425478 hasConcept C2776415932 @default.
• W4200425478 hasConcept C2779013556 @default.
• W4200425478 hasConcept C2779965526 @default.
• W4200425478 hasConcept C502942594 @default.
• W4200425478 hasConcept C55493867 @default.
• W4200425478 hasConcept C71924100 @default.

• next